🇺🇸 FDA
Pipeline program

Goserelin 3.6 mg implant

GnRHa

Unknown small_molecule completed

Quick answer

Goserelin 3.6 mg implant for Postpartum Depression is a Unknown program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).

Program details

Company
INTEGRATED BIOPHARMA INC
Indication
Postpartum Depression
Phase
Unknown
Modality
small_molecule
Status
completed

Clinical trials